Quarter & Nine Months Ended December 2022 : Q3 FY23
"This Presentation, except for the historical information, may contain statements, including the words or phrases such as 'expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should' and similar expressions or variations of these expressions or negatives of these terms indicating future performance or results, financial or otherwise of Tata Chemicals Limited, its direct and indirect subsidiaries and its associates. Actual results might differ substantially or materially from those expressed or implied. Important factors that could make a difference to the Company's operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas markets in which the Company operates, changes in Government policies and regulations, tax laws, and other statutes and incidental factors. You are urged to view all statements contained herein with caution. Tata Chemicals Limited does not undertake any obligation to update or revise forward look statements, whether as a result of new information, future events or otherwise"
2
3
Q3 FY23
9M FY23
▪
Higher revenue on account of better realizations and
stable demand
▪
Input costs still elevated but stable
4,148 Cr (CY) vs ₹ 3,141Cr (PY)
922 Cr (CY) vs. ₹ 546 Cr (PY)
523 Cr (CY) vs. ₹ 246 Cr (PY)
432 Cr (CY) vs ₹ 340 Cr (PY)
12,382 Cr (CY) vs ₹ 9,141Cr (PY)
2,857 Cr (CY) vs. ₹ 1,648 Cr (PY)
1,773 Cr (CY) vs. ₹ 728 Cr (PY)
1,758 Cr (CY) vs ₹ 930 Cr (PY)
▪ EBITDA growth driven by higher realizations in all
geographies
▪ Gross debt lower due to prepayment of debt US$ 144
Mn in overseas units during 9 months (Rs 1150 Cr)
➢ Gross debt down from US $ 930 to US $ 780
➢ Net debt primarily impacted by adverse exchange
rate movement with a forex revaluation impact
Gross Debt
₹ 7,024 Cr
548
₹ 6,476 Cr
(Mar 22)
(Dec 22)
Net Debt
₹ 4,232 Cr
125
₹ 4,357 Cr
(Mar 22)
(Dec 22)
of Rs 410 Cr
4
Revenue
4,239 4,148
3,141
Q3 Dec 21 Q2 Sep 22 Q3 Dec 22
Revenue up by ₹ 1,007 Crore (↑32%)
Consolidated | ₹ Crore
EBITDA
Profit Before Tax
Profit After Tax
920
922
723
685
546
406
534
340
432
Q3 Dec 21 Q2 Sep 22
Q3 Dec 22
Q3 Dec 21 Q2 Sep 22 Q3 Dec 22
Q3 Dec 21 Q2 Sep 22
Q3 Dec 22
EBITDA up by ₹ 376 Crore (↑69%)
PBT up by ₹ 128 Crore (↑32%)
PAT up by ₹ 92 Crore (↑27%)
Standalone | ₹ Crore
Revenue
EBITDA
Profit Before Tax
Profit After Tax
931
1,185
1,218
244
294
284
213
277
244
155
243
190
Q3 Dec
21 Q2 Sep 22
Q3 Dec 22
Q3 Dec 21
Q2 Sep 22
Q3 Dec 22
Q3 Dec
21
Q2 Sep 22
Q3 Dec 22
Q3 Dec
21
Q2 Sep 22
Q3 Dec
22
Revenue up by ₹ 287 Crore (↑31%)
EBITDA up by ₹ 40 Crore (↑16%)
PBT up by ₹ 31 Crore (↑15%)
PAT up by ₹ 35 Crore (↑23%)
Note: Change is vs PY quarter
5
PBT & PAT includes continuing operations, after share in JV & associates & before Non-Controlling Interest
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Tata Chemicals Limited published this content on 01 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2023 13:27:05 UTC.
Tata Chemicals Limited is an India-based sustainable chemistry solutions company. The Company's segments include Basic Chemistry Products and Specialty Products. Basic Chemistry Products segment comprises inorganic chemicals, such as soda ash, salt and sodium bicarbonate. These inorganic chemicals service industries, such as glass (automotive, architectural and container), detergent, food, pharma, animal feed and industrial chemicals. It has manufacturing operations across four continents: North America (United States of America), Europe (United Kingdom), Africa (Kenya) and Asia (India). Specialty Products segment includes three products: specialty silica, prebiotics and Agri inputs. Its specialty silica range serves food, rubber and tire industry. Its prebiotics and formulations are targeted at food, animal feed and pharmaceutical applications. The Company's subsidiary, Rallis India Limited, produces and markets a range of Agri inputs including seeds for Indian and overseas farmers.